Ikarian Capital, LLC VYNE — VYNE THERAPEUTICS INC

Ownership history in Ikarian Capital, LLC  ·  4 quarters on record

AI Ownership Summary

Ikarian Capital, LLC reported VYNE THERAPEUTICS INC (VYNE) in 4 quarterly 13F filings from 2025 Q2 through 2026 Q1. Peak portfolio weight reached 0.09% in 2025 Q2. The latest visible filing shows VYNE at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this VYNE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Ikarian Capital, LLC's position in VYNE THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

VYNE was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.09% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

VYNE stock page Ikarian Capital, LLC fund profile Ikarian Capital, LLC full holdings
How Ikarian Capital, LLC held VYNE — position size vs. price
% of Fund (quarterly)    VYNE price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 4 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED — — — 264,912 — 0% 0.01% $158K 2026-05-15 $0.67
2025 Q4 REDUCED 8.7% +3.5% ❌ 264,912 -25,088 -8.7% 0.01% $154K 2026-02-18 $0.60
2025 Q3 UNCHANGED — — — 290,000 — 0% 0.01% $97K 2025-11-14 $0.37
2025 Q2 INITIATED — — — 290,000 — — 0.09% $479K 2025-08-14 $0.35

🏢 Other funds also holding VYNE

As of 2026 Q1 — sorted by position size

T3 Companies, LLC 0.74% KVP Capital Advisors, LP 0.22% Lynx1 Capital Management LP 3Y 0.15% Shay Capital LLC 3Y 0.08% Rangeley Capital, LLC 0.07% Anson Funds Management LP 3Y 7Y 0.07% Nantahala Capital Management, LLC 3Y 7Y 0.04% ADAR1 Capital Management, LLC 0.04% BRAIDWELL LP 3Y 0.02% FNY Investment Advisers, LLC 3Y 7Y 0.01%

FAQ About Ikarian Capital, LLC and VYNE

These are the practical questions this page is built to answer before you even open the full history table.

How long has Ikarian Capital, LLC reported owning VYNE?

Ikarian Capital, LLC reported VYNE across 4 quarterly 13F filings, from 2025 Q2 through 2026 Q1.

What was the largest reported VYNE position in Ikarian Capital, LLC's portfolio?

The largest reported portfolio weight for VYNE was 0.09% in 2025 Q2.

What is the latest reported VYNE position on this page?

The most recent filing on this page is 2026 Q1, when Ikarian Capital, LLC reported 264,912 shares, equal to 0.01% of portfolio, with an estimated market value of $158K.

What does the chart on this VYNE ownership page compare?

The chart compares Ikarian Capital, LLC's quarterly VYNE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Ikarian Capital, LLC Holdings